Showing results (1651-1660 of 1,762) with videos related to

Sort By:
Pageof 177
Cancer Research|March 31, 2025
The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative EffectNancy Klemm, Roman R Schimmer, Nils K Konrad, et al.
Frontiers in Immunology|June 17, 2017
Mechanisms of Autoantibody-Induced PathologyRalf J Ludwig, Karen Vanhoorelbeke, Frank Leypoldt, et al.
The Journal of Experimental Medicine|March 19, 2014
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groupsMarie-Luise Berres, Karen Phaik Har Lim, Tricia Peters, et al.
Cell Chemical Biology|March 5, 2020
Targeting the PI5P4K Lipid Kinase Family in Cancer Using Covalent InhibitorsSindhu Carmen Sivakumaren, Hyeseok Shim, Tinghu Zhang, et al.
Physical Review Letters|September 26, 2012
Frequency-resolved nonlinear turbulent energy transfer into zonal flows in strongly heated L-mode plasmas in the HL-2A tokamakM Xu, G R Tynan, P H Diamond, et al.
Blood Advances|February 24, 2026
MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similaritiesEmma L Boertjes, Tim Grob, Adil Al Hinai, et al.
Annals of Hematology|August 17, 2023
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) StudySusanne Isfort, Kirsi Manz, Lino L Teichmann, et al.
Blood Advances|January 13, 2026
MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similaritiesEmma L Boertjes, Tim Grob, Adil Salim Abdullah Al Hinai, et al.
European Journal of Haematology|May 30, 2021
Bimodal expression of potential drug target CLL-1 (CLEC12A) on CD34+ blasts of AML patientsLok Lam Ngai, Connie Y Ma, Orla Maguire, et al.
Gut Microbes|July 21, 2025
Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel diseaseYasser Morsy, Åsa Walberg, Paulina Wawrzyniak, et al.
Pageof 177